Logo

Genome-Based Therapeutics: Targeted Drug Discovery and Development

Small book cover: Genome-Based Therapeutics: Targeted Drug Discovery and Development

Genome-Based Therapeutics: Targeted Drug Discovery and Development

Publisher: National Academies Press
Number of pages: 89

Description:
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.

Home page url

Download or read it online for free here:
Download link
(940KB, PDF)

Similar books

Book cover: Drug Class ReviewsDrug Class Reviews
by - Oregon Health & Science University
Contents: Agents for Overactive Bladder; Atypical Antipsychotic Drugs; Beta Adrenergic Blockers; Calcium Channel Blockers; Constipation Drugs; Inhaled Corticosteroids; Drugs for Neuropathic Pain; Newer Antiemetics; Newer Antihistamines; etc.
(15228 views)
Book cover: Enzyme Inhibition and BioapplicationsEnzyme Inhibition and Bioapplications
by - InTech
A concise book on applied methods of enzymes used in drug testing. It will serve the purpose of applied drug evaluation methods in research projects, as well as experienced enzyme scientists who might wish to develop their experiments further.
(9921 views)
Book cover: Pharmacology and TherapeuticsPharmacology and Therapeutics
by - InTech
This book covers six sections: Molecular Modeling and Bio-molecular Pharmacology, Immunopharmacology, Environmental Pharmacology and Toxicology, Nanotechnology and Chemotherapy, Drugs and Drug Delivery System and Addiction Pharmacology.
(9925 views)
Book cover: NeurotoxinsNeurotoxins
by - InTech
Because the incidence of neurobehavioral hazards and risks of exogenous compounds remain subject matter of interest, predictive tools have evolved, including novel translational in vitro models, biomarkers, newer epidemiological research tools, etc.
(6796 views)